200 related articles for article (PubMed ID: 1380648)
1. 5-Azacytidine treatment of HA-A melanoma cells induces Sp1 activity and concomitant transforming growth factor alpha expression.
Shin TH; Paterson AJ; Grant JH; Meluch AA; Kudlow JE
Mol Cell Biol; 1992 Sep; 12(9):3998-4006. PubMed ID: 1380648
[TBL] [Abstract][Full Text] [Related]
2. Protein interactions at Sp1-like sites in the TGF alpha promoter as visualized by in vivo genomic footprinting.
Chen X; Wright KL; Berkowitz EA; Azizkhan JC; Ting JP; Lee DC
Oncogene; 1994 Nov; 9(11):3179-87. PubMed ID: 7936640
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling.
Lai CF; Feng X; Nishimura R; Teitelbaum SL; Avioli LV; Ross FP; Cheng SL
J Biol Chem; 2000 Nov; 275(46):36400-6. PubMed ID: 10964912
[TBL] [Abstract][Full Text] [Related]
4. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells.
Poncelet AC; Schnaper HW
J Biol Chem; 2001 Mar; 276(10):6983-92. PubMed ID: 11114293
[TBL] [Abstract][Full Text] [Related]
5. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine.
Ammanamanchi S; Kim SJ; Sun LZ; Brattain MG
J Biol Chem; 1998 Jun; 273(26):16527-34. PubMed ID: 9632722
[TBL] [Abstract][Full Text] [Related]
6. The binding of transcription factor Sp1 to multiple sites is required for maximal expression from the rat transforming growth factor alpha promoter.
Chen X; Azizkhan JC; Lee DC
Oncogene; 1992 Sep; 7(9):1805-15. PubMed ID: 1501890
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site.
Inagaki Y; Truter S; Ramirez F
J Biol Chem; 1994 May; 269(20):14828-34. PubMed ID: 8182090
[TBL] [Abstract][Full Text] [Related]
8. 5-azaC treatment enhances expression of transforming growth factor-beta receptors through down-regulation of Sp3.
Ammanamanchi S; Brattain MG
J Biol Chem; 2001 Aug; 276(35):32854-9. PubMed ID: 11443124
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio.
Chadjichristos C; Ghayor C; Herrouin JF; Ala-Kokko L; Suske G; Pujol JP; Galéra P
J Biol Chem; 2002 Nov; 277(46):43903-17. PubMed ID: 12186868
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation.
Gille J; Swerlick RA; Caughman SW
EMBO J; 1997 Feb; 16(4):750-9. PubMed ID: 9049304
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site.
Li JM; Nichols MA; Chandrasekharan S; Xiong Y; Wang XF
J Biol Chem; 1995 Nov; 270(45):26750-3. PubMed ID: 7592908
[TBL] [Abstract][Full Text] [Related]
12. Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2.
Venkatasubbarao K; Ammanamanchi S; Brattain MG; Mimari D; Freeman JW
Cancer Res; 2001 Aug; 61(16):6239-47. PubMed ID: 11507078
[TBL] [Abstract][Full Text] [Related]
13. Specific protein-1 is a universal regulator of UDP-glucose dehydrogenase expression: its positive involvement in transforming growth factor-beta signaling and inhibition in hypoxia.
Bontemps Y; Vuillermoz B; Antonicelli F; Perreau C; Danan JL; Maquart FX; Wegrowski Y
J Biol Chem; 2003 Jun; 278(24):21566-75. PubMed ID: 12682078
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors.
Heegaard AM; Xie Z; Young MF; Nielsen KL
J Cell Biochem; 2004 Oct; 93(3):463-75. PubMed ID: 15372625
[TBL] [Abstract][Full Text] [Related]
15. Laminin reduces expression of the human alpha6 integrin subunit gene by altering the level of the transcription factors Sp1 and Sp3.
Gaudreault M; Vigneault F; Leclerc S; Guérin SL
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3490-505. PubMed ID: 17652716
[TBL] [Abstract][Full Text] [Related]
16. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
17. Induction of 12-lipoxygenase expression by transforming growth factor-alpha in human epidermoid carcinoma A431 cells.
Chen LC; Chen BK; Liu YW; Chang WC
FEBS Lett; 1999 Jul; 455(1-2):105-10. PubMed ID: 10428482
[TBL] [Abstract][Full Text] [Related]
18. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.
Periyasamy S; Ammanamanchi S; Tillekeratne MP; Brattain MG
Oncogene; 2000 Sep; 19(40):4660-7. PubMed ID: 11030155
[TBL] [Abstract][Full Text] [Related]
19. Biglycan gene expression in the human leiomyosarcoma cell line SK-UT-1. Basal and protein kinase A-induced transcription involves binding of Sp1-like/Sp3 proteins in the proximal promoter region.
Ungefroren H; Gellersen B; Krull NB; Kalthoff H
J Biol Chem; 1998 Oct; 273(44):29230-40. PubMed ID: 9786935
[TBL] [Abstract][Full Text] [Related]
20. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.
Huang W; Zhao S; Ammanamanchi S; Brattain M; Venkatasubbarao K; Freeman JW
J Biol Chem; 2005 Mar; 280(11):10047-54. PubMed ID: 15647279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
